Munich, Germany, and London, UK, 27 September 2006 - Trigen, the cardiovascular drug discovery and development company, today announced the appointment of Grahame Cook as a non-executive member of its Supervisory Board with effect from 30 August 2006. He will also establish and chair Trigen's Audit Committee.
